These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27829332)

  • 21. [Determination of four amide synthetic cannabinoid isomers by ultra-high performance liquid chromatography-high resolution mass spectrometry].
    Tang R; Wang J; Xiao T; Qin S; Jie Z; Zhang A
    Se Pu; 2024 Jan; 42(1):84-91. PubMed ID: 38197209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid and sensitive screening and confirmation of thirty-four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood.
    Tynon M; Homan J; Kacinko S; Ervin A; McMullin M; Logan BK
    Drug Test Anal; 2017 Jun; 9(6):924-934. PubMed ID: 27653946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of ADB-BUTINACA Metabolites in Human Urine, Blood, Kidney and Liver.
    Kavanagh P; Pechnikov A; Nikolaev I; Dowling G; Kolosova M; Grigoryev A
    J Anal Toxicol; 2022 Jul; 46(6):641-650. PubMed ID: 34341821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of AMB-FUBINACA Biotransformation Pathways in Human Liver Microsome and Zebrafish Systems by Liquid Chromatography-High Resolution Mass Spectrometry.
    Xu DQ; Zhang WF; Li J; Wang JF; Qin SY; Lu JH
    Front Chem; 2019; 7():240. PubMed ID: 31041306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADB-HEXINACA-a novel synthetic cannabinoid with a hexyl substituent: phase I metabolism in authentic urine samples, a case report and prevalence on the German market.
    Giorgetti A; Zschiesche A; Groth O; Haschimi B; Scheu M; Pelletti G; Fais P; Musshoff F; Auwärter V
    Drug Test Anal; 2024 Feb; ():. PubMed ID: 38350637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enantiospecific Synthesis, Chiral Separation, and Biological Activity of Four Indazole-3-Carboxamide-Type Synthetic Cannabinoid Receptor Agonists and Their Detection in Seized Drug Samples.
    Antonides LH; Cannaert A; Norman C; Vives L; Harrison A; Costello A; Nic Daeid N; Stove CP; Sutcliffe OB; McKenzie C
    Front Chem; 2019; 7():321. PubMed ID: 31157203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA.
    Wohlfarth A; Castaneto MS; Zhu M; Pang S; Scheidweiler KB; Kronstrand R; Huestis MA
    AAPS J; 2015 May; 17(3):660-77. PubMed ID: 25721194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schedules of Controlled Substances: Extension of Temporary Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA in Schedule I of the Controlled Substances Act. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Feb; 81(24):6175-7. PubMed ID: 26859904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic fate of the new synthetic cannabinoid 7'N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometry.
    Richter LHJ; Maurer HH; Meyer MR
    Drug Test Anal; 2019 Feb; 11(2):305-317. PubMed ID: 30160067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
    Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
    Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
    Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
    J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatal intoxication by 5F-ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS.
    Kusano M; Zaitsu K; Taki K; Hisatsune K; Nakajima J; Moriyasu T; Asano T; Hayashi Y; Tsuchihashi H; Ishii A
    Drug Test Anal; 2018 Feb; 10(2):284-293. PubMed ID: 28544560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations.
    Lam RPK; Tang MHY; Leung SC; Chong YK; Tsui MSH; Mak TWL
    Clin Toxicol (Phila); 2017 Aug; 55(7):662-667. PubMed ID: 28393558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Validation of a Rapid Method for Identification of New Synthetic Cannabinoids in Hair Based on High-Performance Liquid Chromatography-Ion Trap Mass Spectrometry Using a Simplified User Interface.
    Musile G; Palacio C; Murari M; Appolonova S; Tagliaro F
    J Anal Toxicol; 2023 Feb; 47(1):72-80. PubMed ID: 35536611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation.
    Wohlfarth A; Scheidweiler KB; Pang S; Zhu M; Castaneto M; Kronstrand R; Huestis MA
    Drug Test Anal; 2016 Aug; 8(8):779-91. PubMed ID: 26331297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
    Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
    Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and quantification of 5F-ADB and its methyl ester hydrolysis metabolite in fatal intoxication cases by liquid chromatography-high resolution mass spectrometry.
    Yeter O; Erol Öztürk Y
    Forensic Sci Int; 2019 Sep; 302():109866. PubMed ID: 31302415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass Spectrometry.
    Carlier J; Diao X; Scheidweiler KB; Huestis MA
    Clin Chem; 2017 May; 63(5):1008-1021. PubMed ID: 28302730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First metabolic profile of PV8, a novel synthetic cathinone, in human hepatocytes and urine by high-resolution mass spectrometry.
    Swortwood MJ; Ellefsen KN; Wohlfarth A; Diao X; Concheiro-Guisan M; Kronstrand R; Huestis MA
    Anal Bioanal Chem; 2016 Jul; 408(18):4845-56. PubMed ID: 27185540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vitro Phase I Metabolic Profiling of the Synthetic Cannabinoids AM-694, 5F-NNEI, FUB-APINACA, MFUBINAC, and AMB-FUBINACA.
    Apirakkan O; Gavrilović I; Cowan DA; Abbate V
    Chem Res Toxicol; 2020 Jul; 33(7):1653-1664. PubMed ID: 32301604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.